Skip to main content
Heidi Cuthbert CEO Grafa
Heidi Cuthbert

Heidi Cuthbert

GrafaCEO & Founder

Founder and CEO of Grafa, leading the company's vision to democratise financial data and empower investors with innovative tools.

Articles by Heidi Cuthbert

Grafa

Merck gains EU approval for Keytruda plus Padcev in bladder cancer

Merck (NYSE:MRK) announced that the European Commission approved KEYTRUDA (pembrolizumab), in combination with Padcev (enfortumab vedotin-ejfv), as neoadjuvant treatment followed by adjuvant treatment after radical cystectomy for adults with resectable muscle-invasive bladder cancer who are ineligible for cisplatin-containing chemotherapy.

Read more: Merck gains EU approval for Keytruda plus Padcev in bladder cancer